BioSyent Inc. (CVE:RX – Get Free Report) insider FAX Capital Corp. sold 500,000 shares of the business’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of C$10.05, for a total transaction of C$5,025,000.00.
BioSyent Stock Performance
CVE:RX traded up C$0.05 during midday trading on Tuesday, reaching C$10.90. The stock had a trading volume of 4,233 shares, compared to its average volume of 6,503. The stock has a market capitalization of C$126.33 million, a P/E ratio of 18.17 and a beta of 0.94. BioSyent Inc. has a 1-year low of C$7.66 and a 1-year high of C$11.45. The company has a debt-to-equity ratio of 3.40, a current ratio of 6.13 and a quick ratio of 6.91. The firm’s fifty day simple moving average is C$10.16 and its 200-day simple moving average is C$9.29.
About BioSyent
Featured Articles
- Five stocks we like better than BioSyent
- Compound Interest and Why It Matters When Investing
- 3 Small Cap Stocks That Insiders Are Buying
- What is the S&P/TSX Index?
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.